🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
REP
$REPL
🔒 US EquitiesReplimune Group Inc
AVG HISTORICAL GAP
+0.42%
MAX GAP RECORD
+14.56%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $REPL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$REPL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (BEFORE OPEN (08:00)) |
-0.69%
|
| Jun 29, 2026 Earnings Release 2026-06-29 (BEFORE OPEN) |
-1.98%
|
| Feb 03, 2026 Earnings Release 2026-02-03 (BEFORE OPEN) |
+0.79%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
-0.23%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
+0.18%
|
| May 22, 2025 Earnings Release 2025-05-22 (BEFORE OPEN) |
+4.02%
|
| Feb 12, 2025 Earnings Release 2025-02-12 (BEFORE OPEN) |
-3.81%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-0.08%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.8%
Bullish Gaps (3)
Bearish Gaps (5)
Neutral / Flat (6)
📖 Intelligence Summary
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗